SPRINTR enables high-quality research on the SPRINTR-Real observational study, addressing broad scientific questions about biomarkers for diagnostics, prognostics, and treatment prediction, as well as related issues related to quality of life and health economics.
One of SPRINTR's goals is to facilitate, streamline, and centralize efforts around clinical studies to support more extensive and improved Swedish clinical research on prostate cancer.
SPRINTR is a research platform for precision medicine that is building a study-ready population. Participants are followed through national registers and analysis results from clinical examinations, tissue, blood, and urine. Participants agree to be contacted for future studies, enabling efficient recruitment for both academic and industry-funded research.
Molecular profiling includes histological assessment and RNA/DNA sequencing of biopsies collected during the diagnostic work-up for prostate cancer. Clinical imaging examinations and digitised (scanned) histology slides are also stored as part of the study. Data are stored in a secure study database, while biological samples are stored in a regional biobank and coded in accordance with the Swedish Biobank Act.
Researchers interested in collaboration, data access, or initiating a study within SPRINTR can contact the PI for further information.
